Skip to main content
Fig. 4 | BMC Cardiovascular Disorders

Fig. 4

From: Safety and efficacy of a cardiovascular polypill in people at high and very high risk without a previous cardiovascular event: the international VULCANO randomised clinical trial

Fig. 4

Graphs with the percentage of patients achieving target LDL-c levels* (a) or BP values** (b) at baseline and after 16 weeks or treatment with the CNIC-polypill strategy or usual care. BP blood pressure; LDL-c low-density lipoprotein colesterol. *LDL-c controlled if < 100 mg/dL (or < 70 mg/dL in subjects with diabetes mellitus and subclinical atherosclerosis). **BP controlled if < 140/90 mm Hg (< 130/80 mmHg in subjects with diabetes mellitus)

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us